FdaApplication
BLA 761165
Identifiers
- fda_app_no: BLA761165
Properties
| Property | Value |
|---|---|
| applicant_name | Sandoz Inc. |
| application_type | BLA |
| approval_date | 2022-08-02 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CIMERLI | RANIBIZUMAB-EQRN | 6MG/ML (0.3MG/0.05ML) | Injection |
| CIMERLI | RANIBIZUMAB-EQRN | 10MG/ML (0.5MG/0.05ML) | Injection |
2 products